🇯🇵 Emgality in Japan

PMDA authorised Emgality on 22 January 2021

Marketing authorisations

PMDA — authorised 22 January 2021

  • Marketing authorisation holder: Eli Lilly Japan K.K.
  • Status: approved

Emgality in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Japan

Frequently asked questions

Is Emgality approved in Japan?

Yes. PMDA authorised it on 22 January 2021; PMDA has authorised it.

Who is the marketing authorisation holder for Emgality in Japan?

Eli Lilly Japan K.K. holds the Japanese marketing authorisation.